Bal Pharma Ltd Performance
Day's Low
₹122.55₹12552 Week's Low
52 Week's High
₹88.95₹157.98
| Returns % | |
| 1 Month Return | -0.6 % |
| 3 Month Return | -7.02 % |
| 1 Year Return | + 17.7 % |
| Market Stats | |
| Previous Close | ₹122.55 |
| Open | ₹125.00 |
| Volume | 9,976.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹195.11Cr |
Bal Pharma Ltd Key Statistics
| P/E Ratio | 24.61 |
| PEG Ratio | 8.23 |
| Market Cap | ₹195.11 Cr |
| P/B Ratio | 1.37 |
| EPS | 4.71 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 10.19 |
Bal Pharma Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹195.11 Cr | 42.89% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹55.88 Cr | 50.29% | 0.50 | ₹1 Cr | ₹67 Cr | |
| NA | ₹1,855.65 Cr | 530.92% | 0.52 | NA | NA | |
| NA | ₹135.25 Cr | 23.29% | 0.54 | NA | NA | |
| NA | ₹1,086.43 Cr | 50.29% | 0.51 | NA | NA |
About Bal Pharma Ltd
Share Price: ₹125.00 per share as on 06 Dec, 2024 04:01 PM
Market Capitalisation: ₹195.11Cr as of today
Revenue: ₹73.69Cr as on September 2024 (Q3 24)
Net Profit: ₹1.04Cr as on September 2024 (Q3 24)
Listing date: 08 May, 2006
| Organisation | Bal Pharma Ltd |
| Headquarters | Bangalore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Bal Pharma Ltd
Bal Pharma Ltd's Low P/E Ratio May Indicate Limited Growth Expectations - 30 May, 2024
Investors may be expecting limited growth rates for Bal Pharma Ltd, resulting in a low P/E ratio of 25.5x. While the company has seen rapid earnings growth in the past year and three-year period, its medium-term trajectory is expected to lag behind the broader market's forecasted expansion.Bal Pharma Q4 FY24 Net Profit Jumps to Rs 5.53 Crore - 29 May, 2024
Bal Pharma's consolidated net profit for Q4 FY24 stood at Rs 5.53 crore, up from Rs 1.61 crore in Q4 FY23. The company's board has declared a dividend of Rs 1.20 per equity share. Bal Pharma stock locked in an upper circuit of 20%.
Insights on Bal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 48.64% to 49.01% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 0.26 Cr → 1.04 Cr (in ₹), with an average increase of 75.0% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, BALPHARMA stock has moved up by 23.4%
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 119.3%
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.13% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 64.2% return, outperforming this stock by 46.5%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 51.23% to 50.86% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 97.08 Cr → 73.49 Cr (in ₹), with an average decrease of 12.4% per quarter
Bal Pharma Ltd Financials
Bal Pharma Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.86% | ||
| Foreign Institutions | 0.13% | 0.54 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.01% | 0.77 | |
| Others | 0% | 0.00 |
Bal Pharma Ltd Key Indicators
Bal Pharma Ltd Valuation
Bal Pharma Ltd in the last 5 years
Lowest (-535.88x)
June 15, 2018
Today (24.61x)
December 6, 2024
Industry (57.44x)
December 6, 2024
Highest (203.65x)
September 12, 2018
Bal Pharma Ltd Earnings and Dividends
Bal Pharma Ltd Earnings Results
Bal Pharma Ltd’s net profit jumped 9.47% since last year same period to ₹1.04Cr in the Q2 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated 300% jump in its net profits since last 3-months.
Read More about Earnings ResultsBal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 1.76%.
Read More about Dividends
Bal Pharma Ltd Technicals Summary
Bearish
Neutral
Bullish
Bal Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Bal Pharma Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Bal Pharma Ltd shares.
Bal Pharma Ltd (BALPHARMA) share price today is ₹125
Bal Pharma Ltd is listed on NSE
Bal Pharma Ltd is listed on BSE
- Today’s highest price of Bal Pharma Ltd is ₹125.
- Today’s lowest price of Bal Pharma Ltd is ₹122.55.
PE Ratio of Bal Pharma Ltd is 24.61
PE ratio = Bal Pharma Ltd Market price per share / Bal Pharma Ltd Earnings per share
Today’s traded volume of Bal Pharma Ltd(BALPHARMA) is 9,976.00.
Today’s market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹195.11Cr.
| Bal Pharma Ltd(BALPHARMA | Price |
|---|---|
52 Week High | ₹157.98 |
52 Week Low | ₹88.95 |
Bal Pharma Ltd(BALPHARMA) share price is ₹125. It is down -20.88% from its 52 Week High price of ₹157.98
Bal Pharma Ltd(BALPHARMA) share price is ₹125. It is up 40.53% from its 52 Week Low price of ₹88.95
| Bal Pharma Ltd(BALPHARMA | Returns |
|---|---|
1 Day Returns | 2.45% |
1 Month Returns | -0.6% |
3 Month Returns | -7.02% |
1 Year Returns | 17.7% |